diabetes, asthma, obesity, osteoporosis, arthritis diabetes obesity osteoporosis arthritis research Merck FrosstÕs researchers actively participate to the enrichment of knowledge outside the company: writing articles, conference participation, and collaboration with various organizations elevating their scientific reputation. With the perfecting of SINGULAR¨ (montelukast sodium) and of VIOXX¨ (rofecoxib), Merck Frosst updated not one but two important medications in the last ten years. Thanks to these advances, the Merck Frosst Centre for Therapeutic Research has carved itself a place among the most prestigious research centres in the world.

diabetes | diabetes | ,obesity | ,osteoporosis | ,arthritis | ,research | ,health |